• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by Sabra Health Care REIT Inc.

    2/5/25 7:11:30 AM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate
    Get the next $SBRA alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    SABRA HEALTH CARE REIT INC

    (Name of Issuer)


    COMMON STOCK

    (Title of Class of Securities)


    78573L106

    (CUSIP Number)


    12/31/2024

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    78573L106


    1Names of Reporting Persons

    STATE STREET CORPORATION
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    MASSACHUSETTS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    9,874,429.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    12,187,852.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    12,187,852.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.2 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    SABRA HEALTH CARE REIT INC
    (b)Address of issuer's principal executive offices:

    18500 VON KARMAN AVENUE SUITE 550 , IRVINE, CALIFORNIA, 92612
    Item 2. 
    (a)Name of person filing:

    STATE STREET CORPORATION;
    (b)Address or principal business office or, if none, residence:

    ONE CONGRESS STREET, SUITE 1, BOSTON MA 02114, UNITED STATES
    (c)Citizenship:

    MA
    (d)Title of class of securities:

    COMMON STOCK
    (e)CUSIP No.:

    78573L106
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    12187852.00
    (b)Percent of class:

    5.2  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    0

     (ii) Shared power to vote or to direct the vote:

    9,874,429

     (iii) Sole power to dispose or to direct the disposition of:

    0

     (iv) Shared power to dispose or to direct the disposition of:

    12,187,852

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    NOT APPLICABLE
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    SSGA FUNDS MANAGEMENT, INC. (IA);STATE STREET GLOBAL ADVISORS (JAPAN) CO., LTD. (IA);STATE STREET GLOBAL ADVISORS EUROPE LIMITED (IA);STATE STREET GLOBAL ADVISORS LIMITED (IA);STATE STREET GLOBAL ADVISORS TRUST COMPANY (IA);STATE STREET GLOBAL ADVISORS, AUSTRALIA, LIMITED (IA);STATE STREET GLOBAL ADVISORS, LTD. (IA);
    Item 8.Identification and Classification of Members of the Group.
     
    If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.


    NOT APPLICABLE
    Item 9.Notice of Dissolution of Group.
     
    Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.


    NOT APPLICABLE

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    STATE STREET CORPORATION
     
    Signature:ELIZABETH SCHAEFER
    Name/Title:SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER
    Date:01/31/2025
    Get the next $SBRA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SBRA

    DatePrice TargetRatingAnalyst
    1/17/2025Buy → Hold
    Truist
    1/7/2025$20.00Mkt Perform → Mkt Outperform
    JMP Securities
    12/5/2024$20.00Outperform → Neutral
    Mizuho
    10/1/2024$16.00 → $20.00Equal Weight → Overweight
    Wells Fargo
    9/13/2024$17.00 → $20.00Neutral → Buy
    Citigroup
    1/30/2024$21.00Buy
    Deutsche Bank
    10/17/2023$16.00Outperform → Market Perform
    BMO Capital Markets
    10/16/2023$13.00 → $15.00Underweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $SBRA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Sabra Health Care REIT Inc.

      SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

      10/18/24 11:35:05 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G/A filed by Sabra Health Care REIT Inc. (Amendment)

      SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

      2/13/24 5:13:53 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G/A filed by Sabra Health Care REIT Inc. (Amendment)

      SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

      2/13/24 2:19:42 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Financials

    Live finance-specific insights

    See more
    • Sabra Reports First Quarter 2025 Results; Reiterates 2025 Guidance

      Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2025. FIRST QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2025 were as follows: Net Income: $0.17 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.37 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.19x Senior Housing - Leased: 1.41x Behavioral Health, Specialty Hospitals and Other: 3.77x Same store managed senior housing Cash NOI increased 16.9% on a year-over-year basis. During the first quarter of 2025, Sabra exercised its option to ac

      5/5/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call

      Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 first quarter earnings release on May 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 first quarter results will be held on Tuesday, May 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/667976677. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, op

      4/21/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Reports Fourth Quarter 2024 Results; Introduces 2025 Guidance

      Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the fourth quarter of 2024. FOURTH QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2024 were as follows: Net Income: $0.19 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.36 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.09x Senior Housing - Leased: 1.36x Behavioral Health, Specialty Hospitals and Other: 3.66x Same store managed senior housing Cash NOI increased 17.9% on a year-over-year basis. As previously announced, in the fourth quarter of 2024, Sabra cl

      2/19/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Sabra Health Care REIT, Inc. to Participate in Nareit's REITweek 2025 Investor Conference and Attend ASHA's 2025 Mid-Year Meeting

      Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Executive Vice President of Finance, will participate in Nareit's REITweek 2025 Investor Conference June 2 – 5, 2025 at the New York Hilton Midtown in New York, New York. Additionally, Talya Nevo-Hacohen, Darrin Smith, and other members of the company, will attend ASHA's 2025 Mid-Year Meeting on June 9 – 10, 2025, at the Omni Interlocken Hotel, in Broom

      5/22/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Reports First Quarter 2025 Results; Reiterates 2025 Guidance

      Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2025. FIRST QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2025 were as follows: Net Income: $0.17 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.37 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.19x Senior Housing - Leased: 1.41x Behavioral Health, Specialty Hospitals and Other: 3.77x Same store managed senior housing Cash NOI increased 16.9% on a year-over-year basis. During the first quarter of 2025, Sabra exercised its option to ac

      5/5/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call

      Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 first quarter earnings release on May 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 first quarter results will be held on Tuesday, May 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/667976677. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, op

      4/21/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Sabra Health Care REIT downgraded by Truist

      Truist downgraded Sabra Health Care REIT from Buy to Hold

      1/17/25 11:05:39 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT upgraded by JMP Securities with a new price target

      JMP Securities upgraded Sabra Health Care REIT from Mkt Perform to Mkt Outperform and set a new price target of $20.00

      1/7/25 8:27:55 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT downgraded by Mizuho with a new price target

      Mizuho downgraded Sabra Health Care REIT from Outperform to Neutral and set a new price target of $20.00

      12/5/24 8:19:25 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    SEC Filings

    See more
    • SEC Form 144 filed by Sabra Health Care REIT Inc.

      144 - Sabra Health Care REIT, Inc. (0001492298) (Subject)

      5/15/25 4:10:13 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • SEC Form 10-Q filed by Sabra Health Care REIT Inc.

      10-Q - Sabra Health Care REIT, Inc. (0001492298) (Filer)

      5/5/25 4:06:34 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)

      5/5/25 4:05:31 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Foster Michael J sold $200,376 worth of shares (11,000 units at $18.22), decreasing direct ownership by 15% to 64,725 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      5/22/25 2:55:39 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Director Porter Clifton J Ii was granted 855 shares, increasing direct ownership by 2% to 48,721 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      3/4/25 2:49:21 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Director Malehorn Jeffrey A. was granted 946 shares, increasing direct ownership by 1.00% to 95,725 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      3/4/25 2:48:55 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Leadership Updates

    Live Leadership Updates

    See more
    • Sabra Health Care REIT Appoints Jessica Flores as Chief Accounting Officer

      Sabra Health Care REIT, Inc. ("Sabra") (NASDAQ:SBRA) today announced that Jessica Flores has been appointed Executive Vice President and Chief Accounting Officer and, in such capacity, has been designated by the Company's Board of Directors as the Company's principal accounting officer. Ms. Flores currently serves as Sabra's Senior Vice President – Finance and Controller, a position she has held since January 2022. Ms. Flores joined Sabra in March 2011 and held various leadership positions overseeing Sabra's accounting during that time. Ms. Flores has over 15 years of experience in accounting, finance and real estate investments, having previously worked for KBS Realty Advisors and Deloit

      1/4/24 9:15:00 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT Appoints Katie Cusack to its Board of Directors

      IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Katie Cusack to its Board of Directors. Ms. Cusack currently serves as Chief Operating Officer of Cornell Capital LLC, a $4 billion private investment firm with offices in New York and Hong Kong. From 2007 to 2020, Ms. Cusack served in various capacities at Credit Suisse, including Chief Operating Officer for the Investment Banking Division in both Asia Pacific and Europe, Middle East and Africa, and as the Head of Ultra-High Net Worth Coverage. Prior to joining Credit Suisse, Ms. Cusack served as a Managing Director at MTS Health Partners LP, where she provided

      1/12/21 9:05:00 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT Appoints Ann Kono to Board of Directors

      IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Ann Kono to its Board of Directors. Ms. Kono currently serves as the chief executive officer of Leda Advisory Group, a management consulting firm she founded in January 2019 that partners with startup companies to advise on growth and scale. Prior to founding Leda, Ms. Kono spent 11 years at Ares Management Corporation, where she held the position of Chief Information and Risk Officer, and oversaw Operational, Investment and Enterprise Risks. Ms. Kono also serves on the board of directors of Stable Road Acquisition Company, a position she has held since 2019. M

      12/21/20 9:00:00 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Cusack Catherine bought $40,315 worth of shares (2,500 units at $16.13), increasing direct ownership by 4% to 60,583 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      2/25/25 5:04:04 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Cusack Catherine bought $101,010 worth of shares (7,000 units at $14.43), increasing direct ownership by 18% to 46,385 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      5/23/24 7:00:45 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate